Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More

News Details

October 02, 2018

EVERSANA proudly sponsors the 2018 RARE Patient Advocacy Summit

EVERSANA, the leading independent provider of global services to the life science industry, is proud to join the rare disease patient community as a sponsor of the Global Genes 2018 RARE Patient Advocacy Summit in Irvine, California, October 3-4. The event is the largest gathering of rare disease patients, advocates and thought leaders, who share a commitment to helping the more than 350 million people impacted by rare disease worldwide.

“We are humbled to stand with Global Genes, and the entire rare disease community, in our collective effort to positively impact the lives of patients and their families,” shared Kathi Henson, Patient Services President, EVERSANA. “That’s why we’re building an integrated services platform to build stronger patient relationships, help bring therapies to market more efficiently, and support healthier outcomes for those we serve every day.”

The EVERSANA platform, unveiled earlier this week, includes companies who have partnered with Global Genes for many years, including Dohmen Life Science Services, Triplefin and the Patient Experience Project. To learn more about the event, visit Global Genes.